{"id":207359,"date":"2026-08-17T15:07:21","date_gmt":"2026-08-17T09:37:21","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=207359"},"modified":"2026-08-17T15:07:23","modified_gmt":"2026-08-17T09:37:23","slug":"denis-chem-lab-q1-fy27-results-pat-2-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/denis-chem-lab-q1-fy27-results-pat-2-crore\/","title":{"rendered":"Denis Chem Lab Q1 FY27 Results: Revenue Flat at Rs 43 Crore, PAT Declines 17% to Rs 2 Crore"},"content":{"rendered":"
<\/div>\n

Denis Chem Lab Q1 FY27: Revenue Rs 43 Cr (+1.67%). PAT Rs 2 Cr (-17.37%). Gross profit Rs 2 Cr vs Rs 3 Cr (-28.08%). Standalone. CMP Rs 70.63 on Aug 13, 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Denis Chem Lab Q1 FY27 results showed standalone revenue essentially flat at Rs 43 crore while PAT fell 17.37% to Rs 2 crore as gross profit declined 28.08% \u2014 margin compression in pharmaceutical operations despite stable revenue.<\/p>\n<\/div>\n

Denis Chem Lab<\/a> Q1 FY27 results showed the standalone pharmaceutical company reporting Rs 43 crore revenue, up just 1.67% from Rs 43 crore in Q1 FY26. Despite revenue stability, gross profit fell 28% from Rs 3 crore to Rs 2 crore \u2014 indicating raw material or API cost inflation that was not recovered through pharmaceutical selling prices.<\/p>\n

The Denis Chem Lab Q1 FY27 results showed gross margin contracting from approximately 7% (Rs 3 Cr on Rs 43 Cr) to 4.7% (Rs 2 Cr on Rs 43 Cr) on flat revenue \u2014 a 2.3 percentage point margin compression from pharmaceutical ingredient cost increases.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n